Dr. Myrna B. Tagayun

M.D. | Neurology


  1199 Main Ave, Suite 5, Clifton
     New Jersey, 07011-2253
  973-253-7737    973-253-0213 Maps & Directions
Dr. Myrna B. Tagayun is a Clifton, New Jersey based neurologist who is specialized in Neurology. Her current practice location is 1199 Main Ave, Suite 5, Clifton. Patients can reach her at 973-253-7737 or can fax her at 973-253-0213. Dr. Myrna B. Tagayun is M.D. in Neurology and her NPI number (Unique professional ID assigned by NPPES) is 1205872785.
Dr. Myrna B. Tagayun specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Myrna B. Tagayun speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Myrna B. Tagayun
Specialization: Neurology
Gender:Female
Credentials: M.D.
Practice Address:1199 Main Ave, Suite 5, Clifton,
New Jersey, 07011-2253
Phone:973-253-7737
Fax:973-253-0213
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1205872785
NPI Enumeration Date: 21 Jun, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Myrna B. Tagayun
1199 Main Ave, Suite 5
Clifton, New Jersey
Zip: 07011-2253
Phone Number: 973-253-7737
Fax Number: 973-253-0213
Patients can reach Dr. Myrna B. Tagayun at 1199 Main Ave, Suite 5, Clifton, New Jersey or can call to book an appointment on 973-253-7737.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.